Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach Merritt syndrome
|
|
- Dylan Day
- 5 years ago
- Views:
Transcription
1 Clin. Lab. Haem. 2002, 24, E. MAZOYER*, O. ENJOLRAS, C. LAURIANà, E. HOUDART, L. DROUET* Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach Merritt syndrome *Immuno-Haematology Laboratory, Multidisciplinary Study Group for Vascular Anomalies and Neuroradiology and Interventional Radiology Department, Hospital Lariboisière, àvascular Surgery Department, Hospital Saint Joseph, Paris, France Summary Keywords Confusion in the nomenclature of vascular malformations has been a major obstacle to the understanding of these conditions, so that misdiagnosis and treatment inconsistencies are common. Coagulation abnormalities occurring in combination with venous malformations (VM) have been misdiagnosed as Kasabach Merritt syndrome (KMS), despite marked differences in clinical features, pathology and treatment. A homogenous group of 24 patients with diffuse limb VM was entered into a retrospective chart review study. The VM affected an upper limb in 12 patients, a lower limb in 10 and both in two. Localized intravascular coagulation (LIC) was characterized by a decrease in fibrinogen (0.5 1 g/l), an increase in d-dimers (2 64 lg/ml) and presence of soluble complex of fibrin (+ to +++). Platelet counts were normal or slightly decreased. Higher VM severity scores were associated with more severe LIC. A number of events such as sclerotherapy, surgery, bone fracture, prolonged immobilization and pregnancy or menstruation triggered conversion of the LIC to disseminated intravascular coagulation (DIC), with bleeding related to factor consumption and multiorgan failure related to disseminated microvascular thrombosis. Clinical symptoms associated with worsening of LIC were pain, thrombosis and bleeding at wound sites or during surgery. None of the patients had the large ecchymotic and inflammatory tumours seen in KMS. Graded permanent elastic compression with heparin therapy was the only effective treatment. In conclusion, VM-associated LIC is a distinctive lifelong coagulopathy that must be differentiated from KMS, which is characterized by platelet trapping within a vascular tumour of infancy. The treatment of the two conditions is very different. Coagulation abnormalities, DIC, treatment, venous malformation Introduction In the literature on vascular malformations, similar nomenclature has often been applied to different conditions (Mulliken, 1988). This has been a major obstacle to the understanding and management of vascular malformations, particularly those accompanied with coagulopathies. The resulting treatment inconsistencies have caused harm to patients in some cases. Accepted for publication 8 May 2002 Correspondence: Elisabeth Mazoyer, Hospital Lariboisière, Angio- Haematology, 2 rue Ambroise Paré, Paris France. elisabeth.mazoyer@lrb.ap-hop-paris.fr Ó 2002 Blackwell Science Limited Vascular abnormalities are divided into two main categories, namely, vascular tumours, produced by cellular proliferation (including infantile haemangioma and more recently described infantile tumours such as kaposiform haemangioendothelioma and tufted angioma) and vascular malformations, characterized by abnormal distorted vascular channels (Enjolras & Mulliken, 1998). Vascular malformations are categorized according to flow velocity and the predominant type of channel. Slow-flow malformations can be composed of capillaries, lymphatics and/or veins, whereas fast-flow malformations include aneurysms and arteriovenous malformations. Coagulopathies occur in a minority of vascular malformations. Kasabach Merritt syndrome (KMS) or phenomenon is 243
2 244 Venous malformation and Kasabach Merritt syndrome defined as profound thrombocytopenia related to platelet trapping within a vascular tumour of infancy, either a kaposiform haemangioendothelioma or a tufted angioma (Kasabach & Merritt, 1940; Jones & Orkin, 1989; Zukerberg, Nickoloff & Weiss, 1993; Enjolras et al., 1997b, Enjolras et al., 2000; Sarkar et al., 1997; Vin-Christian, McCalmont & Frieden, 1997). Coagulation abnormalities also occur in children and adults with slow-flow venous or venous-lymphatic malformations (Enjolras et al., 1997a), whose clinical, radiological and pathological features are very different from those of the vascular tumours associated with KMS. The purpose of this retrospective study of 24 patients with diffuse limb venous malformations (VMs) was to illustrate the characteristics of VM-associated coagulation disorders, to establish guidelines for management, and to differentiate this situation from KMS with the goal of avoiding further misdiagnosis and mismanagement (Straub et al., 1972; Mewes et al., 1989; Maceyko & Camisa, 1991; Shoji et al., 1998; Hall, 2001). Patients and methods The study included 24 patients who had been followed for many years at our Multidisciplinary Unit for Vascular Anomalies; nine had been monitored from childhood into adulthood. These 24 patients had similar limb VMs with impaired motility, intermittent muscle and joint pain, and joint swelling or locking. Magnetic resonance imaging (MRI) with T2-weighted sequences and/or computed tomography (CT) with iodinated contrast injection were performed to evaluate the involvement of skin, muscles, joints and/or organs. A severity scoring system based on the number of limbs and tissue types involved by the VM was used. One point was given for each site, as follows: one limb ¼ 1 point; two limbs or more ¼ 2 points; skin, muscle, bone or joint, organ (gastrointestinal tract, kidney), trunk and genitalia ¼ 1 point each. Thus, the highest possible score was 8. Coagulation tests were done during a period of disease stability. A blood sample was drawn from a peripheral vein not affected by the VM, into a tube containing m of trisodium citrate. The prothrombin time (PT; Neoplastine ISI 1.86, Diagnostica Stago, France; normal, 12.9 s), factor V (FV) level (STA-Deficient V, Diagnostica Stago, France; normal, %), and fibrinogen (Fg) level (Von Clauss technique, Fibromat, Bio Merieux, France; normal, 2 4 g/l) were determined using the same coagulation device (STA, Diagnostica Stago). Plasma d-dimers (Asserachrom D-Di, ELISA, Stago, France; normal < 0.5 lg/ml) and plasma-soluble fibrin complexes (F-S-test, Latex Hemagglutination, Stago, France) were assayed. Platelets in an EDTA blood sample were counted using an automated instrument (STKS, Beckman Coulter, Paris, France). Results The characteristics of the 24 patients are summarized in Table 1. There were 18 women and six men. An upper limb (Figure 1) was affected in 12 patients, a lower limb (Figure 2) in 10, and both in two. Skin temperature was normal. The VMs were blue, non-pulsating, soft masses that were compressible on palpation or easily emptied by elevation of the limb. Their size was substantially diminished by permanent elastic compression but only as long as compression was maintained. Imaging studies showed that all VMs involved the skin and muscles. One or more joints were involved in 15 patients. All patients complained of pain in the involved skin and muscles, particularly when waking up in the morning. Involvement of the knee (n ¼ 7) or elbow (n ¼ 7) resulted in severe disability, with episodes of joint locking followed, after several years, by permanent flexion contracture (n ¼ 6). Three patients experienced bleeding from an organ involved by the VM. Phleboliths within the VM were palpable in all 24 patients and were visible as round calcifications on plain radiographs, CT scans, or MRI scans. The size of the limb VM by MRI (Figure 3) was usually larger than expected based on physical findings. Coagulation abnormalities were present consistently but varied in severity. Platelet counts were normal or slightly decreased (range /l). Plasma fibrinogen was low (range g/l), plasma d-dimers were elevated (range lg/ml), and circulating soluble fibrin complexes were detected in some patients (range, + to +++). The PT was increased only in those patients with extensive VM, the mechanism being consumption of fibrinogen and factor V. When localized intravascular coagulation (LIC) was present, its severity was greatest in patients with the highest VM severity scores (Table 1). Several events modified the course of the chronic LIC: discontinuation of elastic compression was followed by a rapid increase in VM size with trapping of blood in the lesion, and sclerotherapy or partial surgical excision of the lesion caused activation of blood coagulation (Figure 4). Other events that influenced the course of LIC were fracture of a bone involved by the VM, prolonged immobilization (for example during a long trip; Figure 5) and menstruation or pregnancy. Low-molecular-weight heparin (LMWH) was the only effective treatment in patients with very severe pain or
3 E. Mazoyer et al. 245 Table 1. Clinical and laboratory test abnormalities in 24 patients with venous malformation (VM) of the limbs Case Sex Limb Other site Extension Score DDE (lg/ml) SC Fg (g/l) Platelets (/mm 3 ) PT (s) 1 F Lower uni M F Lower uni C F Lower uni C M J F Lower uni Trunk C M F Lower uni Trunk + genitalia C M J F Lower uni Trunk + genitalia C M BJ M Lower uni Trunk + genitalia C M J M Lower uni Trunk + genitalia C M J F Lower bilat Trunk + genitalia C M J M Lower bilat Trunk + genitalia + organs C M F Upper uni C M Upper uni C M Upper uni C M F Upper uni One side of trunk C M F Upper uni One side of trunk C M J F Upper uni One side of trunk C M BJ F Upper uni One side of trunk C M BJ F Upper uni One side of trunk C M J F Upper uni One side of trunk C M J F Upper uni One side of trunk C M BJ M Upper uni One side of trunk C M BJ F Upper uni Trunk C F Upper + lower 24 F Upper + lower uni One side of trunk and face C M BJ bilat Trunk + genitalia C M BJ S: skin; M: muscle; J: joint; and B: bone. Extent and severity of the VM were evaluated using an 8-point scale. The following clotting parameters were determined: d-dimers (DDE) (lg/ ml), soluble fibrin complexes (SFC) ( to + + +), fibrinogen (Fg) (g/l), blood platelet count (Platelet) (/mm 3 ), and prothrombin time (PT) (seconds).
4 246 Venous malformation and Kasabach Merritt syndrome Figure 1. Case 21: child with a congenital venous malformation in the right upper limb and right half of the trunk, with severe local intravascular coagulation. The blue colour of the skin was produced by enlarged and distorted venous channels in the dermis. Phleboliths were felt within the vascular lesions. bleeding. Early in our experience, we used antiplatelet agents (aspirin, ticlopidine alone or with aspirin), and oral vitamin K antagonists, to no effect (Figure 6). LMWH was effective in preventing pain, bleeding (particularly from the gastrointestinal tract), excessive bleeding during surgery in the area of the VM and laboratory test alterations. LMWH was always indicated on clinical grounds to alleviate the pain and to improve motility. Some patients required treatment for only a few days or weeks during an acute episode, while others received LMWH repeatedly, for instance during menstruation, and others needed prolonged or continuous LMWH therapy. One patient (case 16) had been treated with LMWH for 21 years with favourable local effects and no osteoporosis or other adverse effects. The case of a 20-year-old European woman with a VM in both lower limbs and coagulation disorders (case 24) illustrates the adverse consequences of misdiagnosing KMS in this situation. She was referred to us at the age of Figure 2. Case 9: girl with a huge congenital venous malformation in both lower limbs and the pelvis, involving the skin, muscles and knees, with gradually worsening functional impairment and moderately severe local intravascular coagulation. 19 with a diagnosis of KMS. The VM was blue and nonpulsating. Skin temperature was normal. Severe swelling occurred when she removed her elastic stockings. CT and MRI showed a typical VM involving the skin, muscles and joints. There was flexion contracture with cartilage destruction of both knees and ankylosis of one ankle. For several years, she had been on interferon a2a, which is used to treat KMS. This treatment had caused marked side-effects but had failed to prevent extension of the VM, formation of painful phleboliths within the VM, increasing functional impairment, severe joint pain followed by joint ankylosis and ulceration of the skin overlying a large phlebolith in the back with severe bleeding and no tendency toward healing. She had been given numerous blood transfusions and had been confined to a wheelchair for the past year. Laboratory test results were as follows: normal platelet count; slight PT increase (17.2 s), low fibrinogen (0.66 g/l), and presence of soluble fibrin complexes (+++) and d-dimers (> 20 lg/ml). The interferon treatment was discontinued, and LMWH was started
5 E. Mazoyer et al. 247 Figure 3. Case 5: Magnetic resonance imaging, T2-weighted sequence. High-intensity signal from the venous malformation within the skin, thigh muscles and knee. in a curative dosage (100 antixaiu/kg twice a day). The bleeding stopped and the blood coagulation abnormalities resolved within 3 weeks (fibrinogen, 2.4 g/l; d-dimers, 3.38 lg/ml; PT, 14.2 s; and soluble complex of fibrin, negative). This allowed surgical removal of the phlebolith in the back and surgical treatment of the ankylosed ankle. She was then able to walk alone with crutches and to resume her university studies. Discussion VMs are slow-flow, haemodynamically inactive vascular malformations. They are present at birth and worsen slowly with advancing age, showing no tendency toward involution, in contrast to haemangiomas and other vascular tumours present at birth or developing in infancy. Males and females are equally affected (Mulliken, 1988; Enjolras et al., 1997a; Wassef & Enjolras, 1999), and the prevalence of females in our group is not typical. Limb VMs can involve not only the skin but also the muscles and joints, as shown by our study. The severity of functional impairment depends on the location of the lesion and on its extension to deep structures. Abdominal VMs can involve the gastrointestinal and genital tracts, causing bleeding. Fifteen of our 24 patients had scores of 5 7 on our 8-point VM-severity scale, and eight of these 15 had severe VM (according to our severity scoring). Blood stagnation with activation of coagulation, consumption of coagulation factors and generation of thrombin and fibrin can occur within the distorted, enlarged, slow-flow venous channels of VMs. This LIC causes pain and thrombosis within the VM. In our patients, LIC severity was positively correlated with VM size. Severe LIC is characterized by low fibrinogen, high d-dimers and the presence of soluble fibrin complexes. LIC should be distinguished from disseminated intravascular coagulation (DIC), which is associated with systemic disorders such as septicaemia. Conversion of LIC to DIC is marked by consumption of platelets and coagulation factors. Increases in PT and decrease in factor V are the earliest signs. In severe forms, bleeding can occur, causing painful haematomas within the VM, haemarthrosis in patients with joint involvement by the VM, or bleeding outside the area of the VM. Severe LIC requires specific treatment to reduce the activation of coagulation and the consumption process, to prevent recurrent intravascular thrombosis and to prevent worsening of the LIC and conversion to DIC. Continuous elastic compression reduces the transmural pressure and parietal distension, thus minimizing blood stasis and local activation of coagulation. Elastic compression not only improves comfort, but also improves the coagulopathy. The management depends on the symptoms. The simplest scenario is the patient requiring cosmetic treatment for a small asymptomatic VM in a single limb segment. In our experience, even the most sensitive tests for activation of coagulation are normal in this situation, and there is no risk of intraoperative bleeding. At the other end of the clinical spectrum is the patient with a large and/or diffuse VM in one or more limbs, sometimes with involvement of the trunk and internal organs. Thromboses within the lesions result in phlebolith formation, pain and impaired function. Laboratory tests often show LIC. Continuous elastic compression reduces the amount of blood trapped in the VM. Long-term LMWH therapy once daily for a few months decreases the risk of thrombosis within the lesions and alleviates the inflammation and pain. When percutaneous sclerotherapy followed by excision of the VM is performed, LMWH therapy before, during and after surgery is indicated, to prevent DIC and bleeding. A third scenario is the patient
6 248 Venous malformation and Kasabach Merritt syndrome Figure 4. Case 20: a 20-year-old woman with an extensive congenital venous malformation involving the skin of the entire upper limb and chest. Severe bleeding with laboratory evidence of disseminated intravascular coagulation (DIC) occurred after excision of the lesions in the tips of the forefinger and ring finger. The activated partial thromboplastin time was normal initially (ratio 1.2). The DIC failed to respond to treatment with fresh frozen plasma (13 units), packed red cells (12 units), platelets (7 units), fibrinogen (1.5 g 19), antithrombin III, aprotinin, and tranexamic acid locally every day. Within 2 days of initiation of low-molecular-weight heparin therapy in a curative dosage, the bleeding stopped and the DIC resolved. Figure 5. Case 10: congenital venous malformation involving the skin and muscles in both lower limbs and pelvis, with moderate chronic local intravascular coagulation. After a long trip, gross haematuria with laboratory test evidence of disseminated intravascular coagulation (DIC) occurred. The initial activated partial thromboplastin time was normal (ratio, 1). Only low-molecular-weight heparin (LMWH) therapy in a curative dosage resulted in gradual resolution of the DIC and, subsequently, of the haematuria. The LMWH therapy was tapered to nothing over several months. Appropriate compression with elastic stockings was prescribed.
7 E. Mazoyer et al. 249 Figure 6. Case 9, same girl as in Figure 2: between 12 and 21 years of age, this patient experienced repeated episodes of thrombosis in the knee, with painful haemarthrosis. Surgical excision of the venous malformation was attempted. When she was 21 years of age, she received low-molecular-weight heparin (LMWH) to treat a large haemarthrosis with worsening local intravascular coagulation (LIC). The initial activated partial thromboplastin time was normal (ratio 1.19). The LIC improved promptly and the pain abated. However, when a vitamin K antagonist was substituted for the heparin the LIC converted to DIC. LMWH therapy was successful. Subsequently, LMWH failed to prevent LIC worsening in association with sclerotherapy. with bleeding from an accidental or surgical wound in the area of the VM. In our experience, LMWH therapy is the only effective means of rapidly stopping the bleeding in this situation. Antiplatelet agents such as aspirin or ticlopidine have provided little or no clinical benefit in patients with VMassociated LIC or DIC. This was to be expected, as the flow conditions within VMs give a predominant role to coagulation factors, with little or no involvement of platelets. In our experience, heparin was far more effective than oral vitamin K antagonists. Heparin was effective in a patient with bleeding 5 days after partial excision of a VM (misdiagnosed as a haemangioma; Elly, 1969). In a pregnant woman with a gluteal VM (according to the photograph shown in the article) misdiagnosed as Klippel Trenaunay syndrome, bleeding occurred a few days after a caesarean section and stopped on initiation of heparin therapy (Neubert, Golden & Rose, 1995). Heparin was effective in a 62-year-old woman with extensive VM of the extremities (misdiagnosed as giant haemangioma) and severe bleeding after excision of a bladder tumour. Corticosteroid treatment was used also but was probably unnecessary (Shoji et al., 1998). In our experience, heparins with lower molecular weights are more effective: we obtained the greatest benefits using CY222, an ultra- LMWH that is not commercially available (Drouet et al., 1993). Coagulation abnormalities associated with limb VMs should not be called KMS, as is often the case in the literature (Table 2). This is extremely important because the treatment of the two conditions differs. Failure to recognize this can lead to complications related to inappropriate treatment, as shown by the case described above. KMS, as described initially in 1940 (Kasabach & Merritt, 1940), is characterized by profound thrombocytopenia (as low as /l) complicating an aggressive infantile vascular tumour, now called kaposiform haemangioendothelioma or tufted angioma (Jones &
8 250 Venous malformation and Kasabach Merritt syndrome Table 2. Main differences between Kasabach Merritt syndrome and venous malformation with local intravascular coagulation Differences Kasabach Merritt syndrome VM-associated LIC Ages Birth and infancy: abnormalities in growth Lifelong LIC with flares and haematological parameters Childhood: resolution of haematological Risk of DIC abnormalities, residual tumour Clinical features Congenital plaque or tumour, or no lesion at birth Sudden development of a distinctive ecchymotic and inflammatory mass Patches or masses, blue colour of skin, soft consistency, normal skin temperature, Swelling when dependent and with exercise Purpura and bruises Haematology Severe thrombocytopenia (often < 5000/mm 3 ), Mild thrombocytopenia or normal platelet count Low fibrinogen Very low fibrinogen Moderate D-Dimer elevation Elevated D-Dimers Course Sudden growth Persists lifelong Involution of the tumour is slow and continues Worsens slowly but continuously after resolution of haematological abnormalities Pathology Kaposiform haemangioendothelioma or tufted angioma Venous malformation Dysplastic venous channels with irregular walls, dissecting the skin and other soft tissues Radio-imaging Doppler: high flow Doppler: no arterial flow, venous slow flow MRI: parenchymal signal, flow voids MRI: high signal on T2 Radiograph: phleboliths Treatments Heparin ineffective Heparin is the only effective drug A number of drugs are effective: corticosteroids, interferon alpha, vincristine, ticlopidine + aspirin. Elastic stocking VM, venous malformation; LIC, local intravascular coagulation; DIC, disseminated intravascular coagulation. Orkin, 1989; Zukerberg, Nickoloff & Weiss, 1993; Enjolras et al., 1997b, Enjolras et al., 2000; Sarkar et al., 1997; Vin-Christian, McCalmont & Frieden, 1997). Although fibrinogen consumption and d-dimer elevation can occur in this life-threatening condition, the predominance of platelet consumption is in contrast to the predominance of coagulation factor consumption that characterizes VM-associated LIC (Enjolras et al., 1997a). The four most effective treatments in KMS are corticosteroids, interferon a, vincristine and ticlopidine plus aspirin. With these agents, the platelet count returns to normal and the tumour decreases in size (Neubert, Golden & Rose, 1995). None of these agents are effective in VM-associated coagulopathies, and heparin therapy is ineffective in KMS. In conclusion, coagulation abnormalities occurring in association with severe VMs of the limbs are a specific entity that must be distinguished from KMS. The coagulopathy persists throughout life, and the course is marked by exacerbations and remissions. When local complications occur or when there is a need for surgery on the affected limb, particularly the joints or muscles, heparin should be given in curative or prophylactic doses, according to the clinical and laboratory test findings. Our experience suggests that LIC may be far more common in patients with limb VMs than in those with craniofacial VMs. Studies are needed to look for other prothrombotic or genetic factors associated with a risk of severe coagulopathy-related symptoms in patients with VM-associated coagulopathy. References Drouet L., Bal dit Sollier J.P., Enjolras O. & Merland J.J. (1993) Is CY222 angiogenic in patients with lymphatic malformation? Thrombosis and Haemostasis 422, 659. Elly G.L. (1969) Heparin therapy for bleeding associated with hemangioma. Surgery 65, Enjolras O., Ciabrini D., Mazoyer E., Laurian C. & Herbreteau D. (1997a) Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. Journal of American Academy of Dermatology 36, Enjolras O. & Mulliken J.B. (1998) Vascular tumors and vascular malformations, new issues. Advances in Dermatology 13, Enjolras O., Mulliken M.W., Wassef M. et al. (2000) Residual lesions of Kasabach Merritt phenomenon in 41 patients. Journal of American Academy of Dermatology 42, Enjolras O., Wassef M., Mazoyer E. et al. (1997b) Infants with Kasabach Merritt syndrome do not have ÔtrueÕ hemangiomas. Journal of Pediatrics 130, Hall G.W. (2001) Kasabach Merritt syndrome: pathogenesis and management. British Journal of Haematology 112,
9 E. Mazoyer et al. 251 Jones E.W. & Orkin M. (1989) Tufted angioma (angioblastoma): a benign progressive angioma not to be confused with Kaposi s sarcoma or low-grade angiosarcoma. Journal of American Academy of Dermatology 20, Kasabach H.H. & Merritt K.K. (1940) Capillary hemangioma with extensive purpura: report of a case. American Journal of Disease in Childhood 59, Maceyko R.F. & Camisa C. (1991) Kasabach Merritt syndrome. Pediatric Dermatology 8, Mewes T., Moldenhauer H., Pfeifer J. & Papenberg J. (1989) The Kasabach Merritt syndrome: severe bleeding disorder caused by celiac arteriography: reversal by heparin treatment. American Journal of Gastroenterology 84, Mulliken J.B. (1988) Classification of vascular birthmarks. In: Vascular Birthmark (Mulliken J.B, Young A, eds), pp W.B. Saunders Company, Philadelphia. Neubert A.G., Golden M.A. & Rose N.C. (1995) Kasabach Merritt coagulopathy complicating Klippel Trenaunay Weber syndrome in pregnancy. Obstetrics and Gynecology 85, Sarkar M., Mulliken J.B., Kozakewich H.P., Robertson R.I. & Borrows P.E. (1997) Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plastic Reconstruction Surgery 100, Shoji N., Nakada T., Sugano O., Suzuki H. & Sasagawa I. (1998) Acute onset of coagulopathy in a patient with Kasabach Merritt syndrome following transurethral resection of bladder tumor. Urology International 61, Straub P.W., Kessler S., Schreiber A. & Frick P.G. (1972) Chronic intravascular coagulation in Kasabach Merritt syndrome. Preferential accumulation of fibrinogen 131 I in a giant hemangioma. Archives of Internal Medicine 129, Vin-Christian K., McCalmont T.H. & Frieden I.J. (1997) Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Archives of Dermatology 133, Wassef M. & Enjolras O. (1999) Les malformations vasculaires superficielles: classifications et histopathologie. Annals of Pathology 19, Zukerberg L.R., Nickoloff B.J. & Weiss S.W. (1993) Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach Merritt syndrome and lymphangiomatosis. American Journal of Surgery and Pathology 17,
Ultrasound imaging of vascular anomalies: pearls and pitfalls
Ultrasound imaging of vascular anomalies: pearls and pitfalls Oscar Navarro, MD Dept. of Medical Imaging, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Declaration of
More informationSonography of soft-tissue vascular lesions
Sonography of soft-tissue vascular lesions Oscar M. Navarro Associate Professor, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Toronto, Canada Declaration of Disclosure
More informationSTUDY. Association of Localized Intravascular Coagulopathy With Venous Malformations
STUDY Association of Localized Intravascular Coagulopathy With Venous Malformations Anne Dompmartin, MD; Aurélie Acher, MD; Pascal Thibon, MD; Sébastien Tourbach, MD; Cédric Hermans, MD, PhD; Véronique
More informationHemangiomas and Other Vascular Tumors
facebook.com/cincykidsrad Hemangiomas and Other Vascular Tumors Disclosures No relevant financial disclosures Bernadette L. Koch, M.D. Departments of Radiology and Pediatrics Cincinnati Children s Hospital
More informationVascular Tumors in Children and Adults. Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine
Vascular Tumors in Children and Adults Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine What are these lesions? (Marcelo Hochman, MD) What are these lesions?
More information2/2/14 INTRODUCTION. Vascular Anomalies: An Introduction to Classification and Coordination of Care. VASCULAR ANOMALIES: History and Classification
INTRODUCTION Vascular Anomalies: An Introduction to Classification and Coordination of Care Cindy Kerr,RN,MSN,CPNP Erin Spera,RN,MSN,CPNP Mary Beth Sylvia,RN,MS,FNP-BC 1in 3 newborns has a vascular birthmark
More informationAngiographic features of rapidly involuting congenital hemangioma (RICH)
Pediatr Radiol (2003) 33: 15 19 DOI 10.1007/s00247-002-0726-3 CASE REPORT Orhan Konez Patricia E. Burrows John B. Mulliken Steven J. Fishman Harry P.W. Kozakewich Angiographic features of rapidly involuting
More informationEnlarging Congenital Soft-Tissue Mass: Venous Malformation Mimicking Hemangioma Vs Sarcoma.
ISPUB.COM The Internet Journal of Plastic Surgery Volume 7 Number 1 Enlarging Congenital Soft-Tissue Mass: Venous Malformation Mimicking Hemangioma Vs Sarcoma. D Dockray, A Smidt, D Meredith, A Shetty
More informationUltrasound of soft-tissue vascular anomalies
Ultrasound of soft-tissue vascular anomalies Oscar M. Navarro Associate Professor, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Toronto, Canada Declaration of Disclosure
More informationUpdate on Vascular Tumors
Update on Vascular Tumors Deepti Gupta, MD Assistant Professor Department of Pediatrics and Division of Dermatology Seattle Children s Hospital University of Washington School of Medicine PHOTOGRAPHY &
More informationIn the 1940s, Kasabach and Merritt
Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon Alla Gruman, MD, a MarilynG.Liang,MD, b,g John B. Mulliken, MD, c,g Steven J. Fishman, MD, d,g Patricia E. Burrows, MD, e,g HarryP.W.Kozakewich,MD,
More informationDeep Vein Thrombosis
Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,
More informationUpdate on Pediatric Vascular Tumors
Update on Pediatric Vascular Tumors Jim Treat, MD Associate Professor of Clinical Pediatrics and Dermatology No Relevant Conflicts of Interest PHOTOGRAPHY & VIDEOTAPING ARE STRICTLY PROHIBITED IN ALL EDUCATIONAL
More informationCoagulation Abnormalities in Pediatric and Adult Patients After Sclerotherapy or Embolization of Vascular Anomalies
Coagulation Abnormalities in Pediatric and Adult Patients After Sclerotherapy or Embolization of Vascular Anomalies Keira P. Mason 1,2 Ellis J. Neufeld 3 Victoria E. Karian 2 David Zurakowski 4 Babu V.
More informationGastrointestinal Hemangiomatosis Joseph Junewick, MD FACR
Gastrointestinal Hemangiomatosis Joseph Junewick, MD FACR 03/06/2010 History 3 month old with protuberant abdomen and anemia. Diagnosis Gastrointestinal Hemangiomatosis Discussion Gastrointestinal hemangiomatosis
More informationVascular malformations and their management
Information for patients Vascular malformations and their management Introduction This leaflet tells you about the condition known as vascular malformation, including venous malformation, arteriovenous
More information3. Discussion. 2 Case Reports in Pediatrics
Case Reports in Pediatrics Volume 2015, Article ID 537530, 4 pages http://dx.doi.org/10.1155/2015/537530 Case Report Paravertebral and Retroperitoneal Vascular Tumour Presenting with Kasabach-Merritt Phenomenon
More informationGLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q
The British Association of Plastic Surgeons (2005) 58, 348 352 GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q J. Leon-Villapalos a, K. Wolfe b, L. Kangesu
More informationSclerotherapy for Venous Vascular and Lymphatic Malformations
Service: Imaging Sclerotherapy for Venous Vascular and Lymphatic Malformations Exceptional healthcare, personally delivered Your doctor has requested that you have sclerotherapy. We hope that the following
More informationClassification des Malformations vasculaires
Classification des Malformations vasculaires Gilles Soulez, MD, MSc, FSIR Professeur Titulaire et Chairman Dpt Radiologie, Radio-Oncologie et Medecine Nucléaire Université de Montréal Basic principles
More informationHIGH-FLOW ARTERIOVENOUS MALFORMATION WİTHİN ENLARGED FETAL LEG (Congenital Hemangioma vs Parkes Weber Syndrome)
HIGH-FLOW ARTERIOVENOUS MALFORMATION WİTHİN ENLARGED FETAL LEG (Congenital Hemangioma vs Parkes Weber Syndrome) DORUK CEVDI KATLAN, MD Department of Obstetrics and Gynecology / Perinatology Suleymaniye
More informationKASABACH MERRITT SYNDROME
KASABACH MERRITT SYNDROME Pages with reference to book, From 159 To 161 Shahina Qureshi, Zaheer Abbasi, Naheed Qadeer, Naila Yaqoob ( Children's Hospital, Pakistan Institute of Medical Sciences, Islamabad.
More informationHemangioma of Tongue with Phlebolith: A Rare presentation
Journal of Government Dental College and Hospital, October 2017, Vol.-04, Issue- 01, P. 20-25 Original article: Hemangioma of Tongue with Phlebolith: A Rare presentation 1 Dr. Jigna S Shah (MDS) 1, 2 Dr.
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationComment je réponds au clinicien qui me demande de classer (selon ISSVA) une tache de naissance?
Comment je réponds au clinicien qui me demande de classer (selon ISSVA) une tache de naissance? Ph. Clapuyt, L. Boon Cliniques universitaires saint Luc Université catholique de Louvain 1200 Bruxelles Les
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/066/5
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationDisseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic
More informationEXTRA-ORAL HEMANGIOMA IN A 10 YEAR OLD GIRL A CASE REPORT WITH LITERATURE REVIEW
EXTRA-ORAL HEMANGIOMA IN A 10 YEAR OLD GIRL A CASE REPORT WITH LITERATURE REVIEW 1 2 2 2 R.Kannan B. Sekar S.Murali Dominic Augustine 1 2 Department of Oral and Maxillofacial Surgery, Department of Oral
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationDisseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.
Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors
More informationAppendix 3 PCC Warfarin Reversal
Appendix 3 PCC Warfarin Reversal Reversal of Warfarin and Analogues 1. Principle of Procedure Guidelines for the Reversal of Oral-anticoagulation in the Event of Life Threatening Haemorrhage Prothrombin
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More informationCase : A Newborn Girl with a Large Cutaneous Lesion, Thrombocytopenia, and Anemia
The new england journal of medicine case records of the massachusetts general hospital Founded by Richard C. Cabot Nancy Lee Harris, m.d., Editor Jo-Anne O. Shepard, m.d., Associate Editor Sally H. Ebeling,
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationEDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION
EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationIntramuscular hemangioma of the forearm; Report of a case
Iran. J. Radiat. Res., 2003; 1(3): 175-179 Intramuscular hemangioma of the forearm; Report of a case M. Vakilha 1, F. Farhan 1, F. Samiei 1, S. Shariat 2 H 1 Radiotherapy-Oncology Dept., Imam Hospital,
More informationJordan M. Garrison, MD FACS, FASMBS
Jordan M. Garrison, MD FACS, FASMBS Peripheral Arterial Disease (PAD) Near or Complete obstruction of > 1 Peripheral Artery Peripheral Venous reflux Disease Varicose Veins Chronic Venous Stasis Ulcer Disease
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationQUICK REFERENCE GUIDE
QUICK REFERENCE GUIDE The recommendations in this publication do not indicate an exclusive course of treatment or serve as a standard of care. Variations, taking into account individual circumstances,
More informationGuidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
More informationSuspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range
Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page
More informationDeep Vein Thrombosis
Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationNon-immune acquired haemolytic anaemias. Dr.Maysem
Non-immune acquired haemolytic anaemias Dr.Maysem Causes of Non-immune acquired haemolytic anaemias. Infections Infections can cause haemolysis in a variety of ways: -They may precipitate an acute haemolytic
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More information10/24/2013. Heparin-Induced Thrombocytopenia (HIT) Anticoagulation Management in ECMO Therapy:
Anticoagulation Management in ECMO Therapy: Heparin-Induced (HIT) Michael H. Creer, MD Professor of Pathology Director, Clinical Laboratories, Medical Co- Director, Hematopathology and Chief, Division
More informationSysmex Educational Enhancement and Development No
SEED Coagulation Sysmex Educational Enhancement and Development No 2 2016 An approach to the bleeding patient The purpose of this newsletter is to provide an overview of the approach to the bleeding patient
More informationClinical analysis of kasabach-merritt syndrome in 17 neonates
Wang et al. BMC Pediatrics 2014, 14:146 RESEARCH ARTICLE Open Access Clinical analysis of kasabach-merritt syndrome in 17 neonates Ping Wang, Wei Zhou *, Li Tao, Ning Zhao and Xiao-Wen Chen Abstract Background:
More informationTRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006
TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.
More informationBeta-blockers in the Treatment of Infantile Hemangiomas 5yrs experience
Beta-blockers in the Treatment of Infantile Hemangiomas 5yrs experience Josef Mališ V.Stará, S.Klovrzová, L.Nováková, M.Kynčl, A.Sukop, B.Kocmichová, Š.Čapková, K.Bláhová Dept. of Pediatric Hematology/Oncology
More informationVascular Imaging in the Pediatric Abdomen. Jonathan Swanson, MD
Vascular Imaging in the Pediatric Abdomen Jonathan Swanson, MD Goals and Objectives To understand the imaging approach, appearance, and clinical manifestations of the common pediatric abdominal vascular
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationQuick Reference Guide SUPPORTED BY:
Quick Reference Guide SUPPORTED BY: 1 The recommendations in this publication do not indicate an exclusive course of treatment or serve as a standard of care. Variations, taking into account individual
More informationMajor Haemorrhage Protocol. Commentary
Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey
More informationKaposiform Hemangioendothelioma: Case Report and Literature Review
288 Chinese Journal of Clinical Oncology Aug. 2007, Vol. 4, No. 4 P 288~292 Gang Zhou et al. [SpringerLink] DOI 10.1007/s11805-007-0289-z Kaposiform Hemangioendothelioma: Case Report and Literature Review
More informationDate: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
More informationHematologic Disorders. Assistant professor of anesthesia
Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
More informationAtherosclerosis. Atherosclerosis happens when the blood vessels
Atherosclerosis Atherosclerosis happens when the blood vessels that carry oxygen and nutrients from your heart to the rest of your body (arteries) become thick and stiff sometimes restricting blood flow
More informationIndex. Note: Page numbers of article numbers are in boldface type.
Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal
More informationThrombosis and emboli. Peter Nagy
Thrombosis and emboli Peter Nagy A thrombus is any solid object developing from the blood in vivo within the vascular system or heart. Thrombosis is hemostasis in the wrong place. Major components, forms:
More informationCONSENT FOR OTOPLASTY
CONSENT FOR OTOPLASTY Otoplasty is a surgical process to reshape the ear. A variety of different techniques and approaches may be used to reshape congenital prominence in the ears or to restore damaged
More informationA Brief Guide Treatment and Prevention
A Brief Guide Treatment and Prevention Deep Vein Thrombosis and Pulmonary Embolism 08/18 Dear reader, This brochure provides you with information about deep vein thrombosis and pulmonary embolism. This
More informationYoung patient with swelling of mandible
HR J Young patient with swelling of mandible, p. 66-71 Clinical Case - Test Yourself Interventional Young patient with swelling of mandible Nikolaos Galanakis 1, Maria Papadaki 2, Dimitrios Tsetis 1 1
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationDeep venous thrombosis and pulmonary embolism in joint replacement surgery
Deep venous thrombosis and pulmonary embolism in joint replacement surgery Even though joint replacement surgery is an effective procedure and in expert hands yields a low complication rate, deep venous
More informationWorld Journal of Surgical Research
Case Report World Journal of Surgical Research Open Access A Rare Case of Servelle Martorelle Syndrome- Extensive Angio-osteohypotrophic Lesion of Upper Limb Ankur Bhatnagar 1, Mayuresh Deshpande 1, V
More informationAnticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT
Haemostasis Thrombosis Phases Endogenous anticoagulants Stopping blood loss Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT Vascular Platelet
More informationKasabach-Merritt Syndrome In A Patient With Klippel- Trenaunay Syndrome Undergoing Massive Transfusion.
ISPUB.COM The Internet Journal of Anesthesiology Volume 28 Number 1 Kasabach-Merritt Syndrome In A Patient With Klippel- Trenaunay Syndrome Undergoing Massive J Bohman, E Wittwer, T Curry, W Hartman Citation
More informationGUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN. All children in whom there is concern regarding bruising / bleeding
GUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN Reference: Bruising / Bleeding / NAI Version No: 1 Applicable to All children in whom there is concern regarding bruising / bleeding Classification
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationGuideline Quick View: Venous Thromboembolism
Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Appropriate and Inappropriate Use of Fresh Frozen Plasma (FFP) and Packed Cell Volume (PCV)
More informationHip Fractures. Anatomy. Causes. Symptoms
Hip Fractures A hip fracture is a break in the upper quarter of the femur (thigh) bone. The extent of the break depends on the forces that are involved. The type of surgery used to treat a hip fracture
More informationVascular surgery is a specialty that deals with diseases of the vascular system (i.e. arteries, veins
Vascular Surgery Vascular surgery is a specialty that deals with diseases of the vascular system (i.e. arteries, veins and lymphatics). These are managed by medical therapy, interventional procedures,
More informationHeart Valve Replacement
Heart Valve Replacement Introduction Sometimes people have serious problems with the valves in their hearts. A heart valve repair or replacement surgery restores or replaces a defective heart valve. If
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationAortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban
doi: 10.2169/internalmedicine.8666-16 http://internmed.jp CASE REPORT Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban Yasuko
More informationDate: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury
More informationInferior Vena Cava Filter for DVT
Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If
More informationThrombolysis and thrombectomy
Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Thrombolysis and thrombectomy This information sheet explains about how a blood is diagnosed and the various forms
More informationThere are two main causes of a low platelet count
Thrombocytopenia Thrombocytopenia is a condition in which a person's blood has an unusually low level of platelets Platelets, also called thrombocytes, are found in a person's blood along with red blood
More informationTreatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin
Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin You have been given this leaflet because you have a blood clot. Normally blood flows freely around the body without
More informationChallenges in Anticoagulation and Thromboembolism
Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives
More informationFrom the Plastic and Jaw Department, United She3~eM Hospitals.
THE " BLUE FLAP ": A METHOD OF TREATMENT By WILFRED HYNES, F.R.C.S. From the Plastic and Jaw Department, United She3~eM Hospitals. THE " blue flap," one of the most difficult problems in surgery, is apt
More informationDr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN
Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets
More informationFeatures compression after open and endovascular operation in vascular malformation
Features compression after open and endovascular operation in vascular malformation Sapelkin Sergey Institute of Surgery named A.V. Vishnevsky, Moscow, Russia 21.10.2017 CIRC Meeting, Grassau AV-malformations:
More informationPrimary Care practice clinics within the Edmonton Southside Primary Care Network.
INR Monitoring and Warfarin Dose Adjustment Last Review: November 2016 Intervention(s) and/or Procedure: Registered Nurses (RNs) adjust warfarin dosage according to individual patient International Normalized
More informationIntravenous Pyelogram (IVP)
Scan for mobile link. Intravenous Pyelogram (IVP) Intravenous pyelogram (IVP) is an x-ray exam that uses an injection of contrast material to evaluate your kidneys, ureters and bladder and help diagnose
More informationCANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital
CANCER ASSOCIATED THROMBOSIS Pankaj Handa Department of General Medicine Tan Tock Seng Hospital My Talk Today 1.Introduction 2. Are All Cancer Patients at Risk of VTE? 3. Should All VTE Patients Be Screened
More information